Rank | Gene Set | Z-score |
---|---|---|
1 | dopamine biosynthetic process (GO:0042416) | 9.06615423 |
2 | catecholamine transport (GO:0051937) | 7.44770887 |
3 | prepulse inhibition (GO:0060134) | 6.86593876 |
4 | phenol-containing compound catabolic process (GO:0019336) | 6.86132032 |
5 | catecholamine biosynthetic process (GO:0042423) | 5.65044609 |
6 | catechol-containing compound biosynthetic process (GO:0009713) | 5.65044609 |
7 | fucose catabolic process (GO:0019317) | 5.60361342 |
8 | L-fucose metabolic process (GO:0042354) | 5.60361342 |
9 | L-fucose catabolic process (GO:0042355) | 5.60361342 |
10 | neurotransmitter biosynthetic process (GO:0042136) | 5.52343006 |
11 | alkaloid metabolic process (GO:0009820) | 5.43292735 |
12 | cellular response to nicotine (GO:0071316) | 5.09620144 |
13 | response to xenobiotic stimulus (GO:0009410) | 5.09303088 |
14 | mating behavior (GO:0007617) | 4.45693350 |
15 | synaptic transmission, dopaminergic (GO:0001963) | 4.41789461 |
16 | neuronal action potential (GO:0019228) | 4.40674867 |
17 | protein polyglutamylation (GO:0018095) | 4.36734491 |
18 | tyrosine metabolic process (GO:0006570) | 4.33733991 |
19 | monoamine transport (GO:0015844) | 4.32697736 |
20 | norepinephrine metabolic process (GO:0042415) | 4.32423112 |
21 | neurofilament cytoskeleton organization (GO:0060052) | 4.31885026 |
22 | neurotransmitter metabolic process (GO:0042133) | 4.13958975 |
23 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.99942719 |
24 | response to manganese ion (GO:0010042) | 3.94548569 |
25 | mechanosensory behavior (GO:0007638) | 3.92471168 |
26 | serotonin metabolic process (GO:0042428) | 3.85124074 |
27 | dopamine metabolic process (GO:0042417) | 3.83964193 |
28 | response to amphetamine (GO:0001975) | 3.80592992 |
29 | negative regulation of neurotransmitter transport (GO:0051589) | 3.79426514 |
30 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.78418607 |
31 | membrane depolarization during action potential (GO:0086010) | 3.77772780 |
32 | response to insecticide (GO:0017085) | 3.77066010 |
33 | glycine transport (GO:0015816) | 3.73548024 |
34 | response to cocaine (GO:0042220) | 3.71616087 |
35 | ovulation cycle (GO:0042698) | 3.71504988 |
36 | cysteine metabolic process (GO:0006534) | 3.67203412 |
37 | cell migration in hindbrain (GO:0021535) | 3.63014777 |
38 | toxin metabolic process (GO:0009404) | 3.57331223 |
39 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.52914182 |
40 | response to nitrosative stress (GO:0051409) | 3.51608927 |
41 | phenol-containing compound biosynthetic process (GO:0046189) | 3.50705730 |
42 | auditory behavior (GO:0031223) | 3.48051828 |
43 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.46345157 |
44 | RNA localization (GO:0006403) | 3.45937273 |
45 | inositol phosphate catabolic process (GO:0071545) | 3.45782574 |
46 | embryonic body morphogenesis (GO:0010172) | 3.45377877 |
47 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.42451467 |
48 | inositol phosphate dephosphorylation (GO:0046855) | 3.42451467 |
49 | primary amino compound metabolic process (GO:1901160) | 3.41588756 |
50 | response to pheromone (GO:0019236) | 3.38817440 |
51 | heparin biosynthetic process (GO:0030210) | 3.36956715 |
52 | heparin metabolic process (GO:0030202) | 3.36956715 |
53 | response to water (GO:0009415) | 3.36591540 |
54 | regulation of synaptic vesicle transport (GO:1902803) | 3.32911891 |
55 | gamma-aminobutyric acid transport (GO:0015812) | 3.29985467 |
56 | regulation of dopamine metabolic process (GO:0042053) | 3.29265958 |
57 | regulation of catecholamine metabolic process (GO:0042069) | 3.29265958 |
58 | positive regulation of neurological system process (GO:0031646) | 3.22401914 |
59 | response to nicotine (GO:0035094) | 3.20079158 |
60 | neurotransmitter transport (GO:0006836) | 3.19994146 |
61 | neuromuscular synaptic transmission (GO:0007274) | 3.19827568 |
62 | regulation of synapse structural plasticity (GO:0051823) | 3.19488512 |
63 | photoreceptor cell development (GO:0042461) | 3.18290534 |
64 | behavioral response to nicotine (GO:0035095) | 3.17984530 |
65 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.15630546 |
66 | retinal cone cell development (GO:0046549) | 3.15208728 |
67 | nucleobase catabolic process (GO:0046113) | 3.14274175 |
68 | eye photoreceptor cell development (GO:0042462) | 3.12511651 |
69 | protein localization to cilium (GO:0061512) | 3.12432011 |
70 | startle response (GO:0001964) | 3.10825210 |
71 | body morphogenesis (GO:0010171) | 2.98374797 |
72 | catechol-containing compound metabolic process (GO:0009712) | 2.98316418 |
73 | catecholamine metabolic process (GO:0006584) | 2.98316418 |
74 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.96748913 |
75 | benzene-containing compound metabolic process (GO:0042537) | 2.94828244 |
76 | neuron cell-cell adhesion (GO:0007158) | 2.93705251 |
77 | synaptic transmission, cholinergic (GO:0007271) | 2.90560289 |
78 | neuron-neuron synaptic transmission (GO:0007270) | 2.89545986 |
79 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.88927098 |
80 | regulation of neurotransmitter levels (GO:0001505) | 2.88833284 |
81 | neuronal action potential propagation (GO:0019227) | 2.83845674 |
82 | fucosylation (GO:0036065) | 2.83561539 |
83 | positive regulation of gastrulation (GO:2000543) | 2.80905428 |
84 | response to corticosterone (GO:0051412) | 2.80681604 |
85 | axonal fasciculation (GO:0007413) | 2.78227156 |
86 | sensory perception of smell (GO:0007608) | 2.77524268 |
87 | dendritic spine morphogenesis (GO:0060997) | 2.77354655 |
88 | establishment of mitochondrion localization (GO:0051654) | 2.75719958 |
89 | positive regulation of mitochondrial fission (GO:0090141) | 2.73785901 |
90 | protein-cofactor linkage (GO:0018065) | 2.72350673 |
91 | regulation of microtubule-based movement (GO:0060632) | 2.71789359 |
92 | synapse assembly (GO:0007416) | 2.71766682 |
93 | neurotransmitter secretion (GO:0007269) | 2.69175639 |
94 | synaptic transmission, glutamatergic (GO:0035249) | 2.66886192 |
95 | negative regulation of macrophage differentiation (GO:0045650) | 2.65528769 |
96 | polyol catabolic process (GO:0046174) | 2.64051273 |
97 | single strand break repair (GO:0000012) | 2.63833379 |
98 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.63544792 |
99 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.63223953 |
100 | dopamine transport (GO:0015872) | 10.3246271 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.93258491 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.89144286 |
3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.86737112 |
4 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 3.18526897 |
5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.13363698 |
6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.87532240 |
7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.77176037 |
8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.76203806 |
9 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.59413276 |
10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.53892755 |
11 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.47868869 |
12 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.42403265 |
13 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.40695815 |
14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.17398967 |
15 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.03510635 |
16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.94487960 |
17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.94371382 |
18 | VDR_22108803_ChIP-Seq_LS180_Human | 1.91148120 |
19 | FUS_26573619_Chip-Seq_HEK293_Human | 1.84055830 |
20 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.79744929 |
21 | P300_19829295_ChIP-Seq_ESCs_Human | 1.78498487 |
22 | STAT3_23295773_ChIP-Seq_U87_Human | 1.69127075 |
23 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.68216824 |
24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.65958425 |
25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.65892084 |
26 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.64790536 |
27 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.62052353 |
28 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.61872182 |
29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.61300718 |
30 | AR_25329375_ChIP-Seq_VCAP_Human | 1.58894317 |
31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.58700597 |
32 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56701857 |
33 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.53015426 |
34 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.53015426 |
35 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.51862126 |
36 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.45391750 |
37 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.43853685 |
38 | TCF4_23295773_ChIP-Seq_U87_Human | 1.43486502 |
39 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.43037277 |
40 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42897579 |
41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.42638578 |
42 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.41698224 |
43 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41651786 |
44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41405229 |
45 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.41190301 |
46 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.40731469 |
47 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.39761676 |
48 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.38542991 |
49 | EWS_26573619_Chip-Seq_HEK293_Human | 1.38433977 |
50 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.38245509 |
51 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.37305535 |
52 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.36517122 |
53 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.36452809 |
54 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36297730 |
55 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.35784243 |
56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31194294 |
57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28295701 |
58 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27564076 |
59 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26645606 |
60 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.25074207 |
61 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.24452136 |
62 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.24340222 |
63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.22781046 |
64 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.21774658 |
65 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.21712320 |
66 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.20542910 |
67 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19021203 |
68 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.17879988 |
69 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.17879988 |
70 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.16893151 |
71 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.16225974 |
72 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.14948733 |
73 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.14948733 |
74 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14370835 |
75 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.14173333 |
76 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.13885146 |
77 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.13741721 |
78 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.12665971 |
79 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12470501 |
80 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.11203171 |
81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.10893769 |
82 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.10762525 |
83 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.10336598 |
84 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.10309874 |
85 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08248120 |
86 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07632938 |
87 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07252150 |
88 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06992236 |
89 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.06321217 |
90 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06193155 |
91 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.04455221 |
92 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04412969 |
93 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.04073902 |
94 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03566399 |
95 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03566399 |
96 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01705052 |
97 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.00624005 |
98 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.00419847 |
99 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98009967 |
100 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.95797514 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0009046_muscle_twitch | 4.09755169 |
2 | MP0001986_abnormal_taste_sensitivity | 3.53575135 |
3 | MP0005423_abnormal_somatic_nervous | 3.20616830 |
4 | MP0001905_abnormal_dopamine_level | 3.18553595 |
5 | MP0003880_abnormal_central_pattern | 2.99604062 |
6 | MP0001188_hyperpigmentation | 2.99114489 |
7 | MP0005646_abnormal_pituitary_gland | 2.68170963 |
8 | MP0001968_abnormal_touch/_nociception | 2.44687078 |
9 | MP0005187_abnormal_penis_morphology | 2.42036607 |
10 | MP0009379_abnormal_foot_pigmentation | 2.33739844 |
11 | MP0002272_abnormal_nervous_system | 2.31004746 |
12 | MP0000569_abnormal_digit_pigmentation | 2.30173334 |
13 | MP0009745_abnormal_behavioral_response | 2.27575492 |
14 | MP0003890_abnormal_embryonic-extraembry | 2.27192286 |
15 | MP0003635_abnormal_synaptic_transmissio | 2.25139661 |
16 | MP0000631_abnormal_neuroendocrine_gland | 2.18624875 |
17 | MP0004142_abnormal_muscle_tone | 2.18539889 |
18 | MP0006072_abnormal_retinal_apoptosis | 2.12939809 |
19 | MP0005645_abnormal_hypothalamus_physiol | 2.11230005 |
20 | MP0002735_abnormal_chemical_nociception | 2.10414407 |
21 | MP0004859_abnormal_synaptic_plasticity | 2.10001603 |
22 | MP0003315_abnormal_perineum_morphology | 2.02792466 |
23 | MP0000778_abnormal_nervous_system | 2.01610645 |
24 | MP0002822_catalepsy | 1.95129686 |
25 | MP0002064_seizures | 1.94020330 |
26 | MP0005551_abnormal_eye_electrophysiolog | 1.90402699 |
27 | MP0002572_abnormal_emotion/affect_behav | 1.80096261 |
28 | MP0002067_abnormal_sensory_capabilities | 1.79575427 |
29 | MP0001486_abnormal_startle_reflex | 1.76554293 |
30 | MP0005253_abnormal_eye_physiology | 1.75414304 |
31 | MP0000750_abnormal_muscle_regeneration | 1.74598127 |
32 | MP0004742_abnormal_vestibular_system | 1.72821514 |
33 | MP0002557_abnormal_social/conspecific_i | 1.71979431 |
34 | MP0002063_abnormal_learning/memory/cond | 1.71945378 |
35 | MP0000955_abnormal_spinal_cord | 1.71507964 |
36 | MP0004133_heterotaxia | 1.69853669 |
37 | MP0008872_abnormal_physiological_respon | 1.67712156 |
38 | MP0004924_abnormal_behavior | 1.67460706 |
39 | MP0005386_behavior/neurological_phenoty | 1.67460706 |
40 | MP0002102_abnormal_ear_morphology | 1.65030977 |
41 | MP0002876_abnormal_thyroid_physiology | 1.56946549 |
42 | MP0006276_abnormal_autonomic_nervous | 1.52073930 |
43 | MP0001984_abnormal_olfaction | 1.50433706 |
44 | MP0002837_dystrophic_cardiac_calcinosis | 1.50145814 |
45 | MP0001529_abnormal_vocalization | 1.48878236 |
46 | MP0003011_delayed_dark_adaptation | 1.48539977 |
47 | MP0002736_abnormal_nociception_after | 1.44718325 |
48 | MP0003787_abnormal_imprinting | 1.42105268 |
49 | MP0003122_maternal_imprinting | 1.40028963 |
50 | MP0002184_abnormal_innervation | 1.39507406 |
51 | MP0002734_abnormal_mechanical_nocicepti | 1.38606406 |
52 | MP0006292_abnormal_olfactory_placode | 1.35042328 |
53 | MP0003283_abnormal_digestive_organ | 1.27810723 |
54 | MP0002882_abnormal_neuron_morphology | 1.27427935 |
55 | MP0002733_abnormal_thermal_nociception | 1.24174484 |
56 | MP0002254_reproductive_system_inflammat | 1.23825656 |
57 | MP0004134_abnormal_chest_morphology | 1.23475106 |
58 | MP0004270_analgesia | 1.20634508 |
59 | MP0008877_abnormal_DNA_methylation | 1.19376148 |
60 | MP0001970_abnormal_pain_threshold | 1.15386485 |
61 | MP0005410_abnormal_fertilization | 1.09215731 |
62 | MP0002752_abnormal_somatic_nervous | 1.09183360 |
63 | MP0002229_neurodegeneration | 1.06606803 |
64 | MP0001502_abnormal_circadian_rhythm | 1.06461638 |
65 | MP0003633_abnormal_nervous_system | 1.04419574 |
66 | MP0002095_abnormal_skin_pigmentation | 1.04250332 |
67 | MP0008875_abnormal_xenobiotic_pharmacok | 1.03816847 |
68 | MP0001440_abnormal_grooming_behavior | 1.02851728 |
69 | MP0004811_abnormal_neuron_physiology | 1.01700960 |
70 | MP0002066_abnormal_motor_capabilities/c | 0.96166667 |
71 | MP0005195_abnormal_posterior_eye | 0.92570430 |
72 | MP0003119_abnormal_digestive_system | 0.90570225 |
73 | MP0002751_abnormal_autonomic_nervous | 0.87140765 |
74 | MP0003879_abnormal_hair_cell | 0.85304379 |
75 | MP0002653_abnormal_ependyma_morphology | 0.84223583 |
76 | MP0002269_muscular_atrophy | 0.81934594 |
77 | MP0004043_abnormal_pH_regulation | 0.81923879 |
78 | MP0005174_abnormal_tail_pigmentation | 0.81622715 |
79 | MP0002152_abnormal_brain_morphology | 0.81474042 |
80 | MP0003631_nervous_system_phenotype | 0.80613993 |
81 | MP0009697_abnormal_copulation | 0.77985621 |
82 | MP0002909_abnormal_adrenal_gland | 0.77957783 |
83 | MP0000613_abnormal_salivary_gland | 0.77168728 |
84 | MP0003121_genomic_imprinting | 0.73951783 |
85 | MP0001485_abnormal_pinna_reflex | 0.72839419 |
86 | MP0001963_abnormal_hearing_physiology | 0.72725599 |
87 | MP0003698_abnormal_male_reproductive | 0.72601777 |
88 | MP0001177_atelectasis | 0.72431953 |
89 | MP0002928_abnormal_bile_duct | 0.72128220 |
90 | MP0000026_abnormal_inner_ear | 0.70818721 |
91 | MP0008569_lethality_at_weaning | 0.68923951 |
92 | MP0002638_abnormal_pupillary_reflex | 0.68654068 |
93 | MP0003252_abnormal_bile_duct | 0.68314977 |
94 | MP0004145_abnormal_muscle_electrophysio | 0.67882714 |
95 | MP0004885_abnormal_endolymph | 0.67109452 |
96 | MP0002090_abnormal_vision | 0.66843214 |
97 | MP0003861_abnormal_nervous_system | 0.66342858 |
98 | MP0003943_abnormal_hepatobiliary_system | 0.66330906 |
99 | MP0001943_abnormal_respiration | 0.66000033 |
100 | MP0005248_abnormal_Harderian_gland | 0.64824109 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Type II lissencephaly (HP:0007260) | 5.33488294 |
2 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 5.19666928 |
3 | Hypokinesia (HP:0002375) | 4.72578038 |
4 | Focal motor seizures (HP:0011153) | 4.29955476 |
5 | Dyskinesia (HP:0100660) | 4.19807760 |
6 | Retinal dysplasia (HP:0007973) | 4.19166782 |
7 | Cerebellar dysplasia (HP:0007033) | 3.89101782 |
8 | Diminished movement (HP:0002374) | 3.61233323 |
9 | Chronic hepatic failure (HP:0100626) | 3.38982816 |
10 | Delayed gross motor development (HP:0002194) | 3.32252690 |
11 | Abnormality of midbrain morphology (HP:0002418) | 3.28820581 |
12 | Molar tooth sign on MRI (HP:0002419) | 3.28820581 |
13 | Agitation (HP:0000713) | 3.17807880 |
14 | Congenital stationary night blindness (HP:0007642) | 3.14399262 |
15 | Morphological abnormality of the pyramidal tract (HP:0002062) | 3.11428042 |
16 | Akinesia (HP:0002304) | 3.11170047 |
17 | Focal seizures (HP:0007359) | 3.06125079 |
18 | Severe muscular hypotonia (HP:0006829) | 3.03825591 |
19 | Optic nerve hypoplasia (HP:0000609) | 3.03496538 |
20 | Nephronophthisis (HP:0000090) | 2.96406678 |
21 | Hyperventilation (HP:0002883) | 2.96346838 |
22 | Postural instability (HP:0002172) | 2.92401986 |
23 | Pancreatic cysts (HP:0001737) | 2.90196005 |
24 | Lissencephaly (HP:0001339) | 2.88559083 |
25 | Amyotrophic lateral sclerosis (HP:0007354) | 2.78141560 |
26 | Pancreatic fibrosis (HP:0100732) | 2.77898546 |
27 | Thickened helices (HP:0000391) | 2.71807950 |
28 | Bradykinesia (HP:0002067) | 2.66434950 |
29 | Medial flaring of the eyebrow (HP:0010747) | 2.64786427 |
30 | Drooling (HP:0002307) | 2.61376228 |
31 | Hemiparesis (HP:0001269) | 2.61366407 |
32 | Gait imbalance (HP:0002141) | 2.54312020 |
33 | Abnormality of the renal medulla (HP:0100957) | 2.54168471 |
34 | Supranuclear gaze palsy (HP:0000605) | 2.49647601 |
35 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.44956277 |
36 | Inability to walk (HP:0002540) | 2.42089231 |
37 | Abnormality of alanine metabolism (HP:0010916) | 2.40087395 |
38 | Hyperalaninemia (HP:0003348) | 2.40087395 |
39 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.40087395 |
40 | Excessive salivation (HP:0003781) | 2.38980982 |
41 | Pendular nystagmus (HP:0012043) | 2.34168622 |
42 | Decreased circulating renin level (HP:0003351) | 2.31918452 |
43 | Anosmia (HP:0000458) | 2.31576913 |
44 | Congenital primary aphakia (HP:0007707) | 2.24951015 |
45 | Generalized tonic-clonic seizures (HP:0002069) | 2.20410730 |
46 | Polydipsia (HP:0001959) | 2.14451520 |
47 | Abnormal drinking behavior (HP:0030082) | 2.14451520 |
48 | Epileptic encephalopathy (HP:0200134) | 2.12866906 |
49 | Tubular atrophy (HP:0000092) | 2.12799916 |
50 | Hypoplasia of the pons (HP:0012110) | 2.10163477 |
51 | Rigidity (HP:0002063) | 2.10035808 |
52 | Muscular hypotonia of the trunk (HP:0008936) | 2.09344846 |
53 | Nephrogenic diabetes insipidus (HP:0009806) | 2.09120605 |
54 | Tachypnea (HP:0002789) | 2.05084799 |
55 | Febrile seizures (HP:0002373) | 2.04430237 |
56 | Polyphagia (HP:0002591) | 2.03635645 |
57 | Exotropia (HP:0000577) | 2.00103745 |
58 | Limb dystonia (HP:0002451) | 11.3042143 |
59 | Dialeptic seizures (HP:0011146) | 1.99108220 |
60 | Poor eye contact (HP:0000817) | 1.98271591 |
61 | Mask-like facies (HP:0000298) | 1.95589979 |
62 | Spastic tetraplegia (HP:0002510) | 1.95359548 |
63 | Gastroesophageal reflux (HP:0002020) | 1.94692440 |
64 | Abnormality of DNA repair (HP:0003254) | 1.93378136 |
65 | True hermaphroditism (HP:0010459) | 1.89926417 |
66 | Conjugated hyperbilirubinemia (HP:0002908) | 1.89867920 |
67 | Narrow forehead (HP:0000341) | 1.82965525 |
68 | Ketoacidosis (HP:0001993) | 1.81894754 |
69 | Renal dysplasia (HP:0000110) | 1.79984748 |
70 | Thyroiditis (HP:0100646) | 1.79336653 |
71 | Protruding tongue (HP:0010808) | 1.77801988 |
72 | Genital tract atresia (HP:0001827) | 1.76229823 |
73 | Cutaneous melanoma (HP:0012056) | 1.75074718 |
74 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.74158029 |
75 | Abnormality of macular pigmentation (HP:0008002) | 1.72288983 |
76 | Large eyes (HP:0001090) | 1.71732077 |
77 | Abnormality of the pons (HP:0007361) | 1.71669537 |
78 | Gaze-evoked nystagmus (HP:0000640) | 1.69969103 |
79 | Vaginal atresia (HP:0000148) | 1.69349132 |
80 | Dysdiadochokinesis (HP:0002075) | 1.68509433 |
81 | Hypothermia (HP:0002045) | 1.67764792 |
82 | Confusion (HP:0001289) | 1.67662136 |
83 | Anterior segment dysgenesis (HP:0007700) | 1.66921342 |
84 | Abnormality of the renal cortex (HP:0011035) | 1.66705018 |
85 | Specific learning disability (HP:0001328) | 1.66646364 |
86 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.65948936 |
87 | Broad-based gait (HP:0002136) | 1.65099027 |
88 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.64752871 |
89 | Intestinal atresia (HP:0011100) | 1.64635870 |
90 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.64523679 |
91 | Myoclonus (HP:0001336) | 1.64357351 |
92 | Septo-optic dysplasia (HP:0100842) | 1.63018602 |
93 | Abnormality of the vitreous humor (HP:0004327) | 1.61701461 |
94 | Long nose (HP:0003189) | 1.61640743 |
95 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.61469748 |
96 | Congenital hepatic fibrosis (HP:0002612) | 1.59889190 |
97 | Generalized myoclonic seizures (HP:0002123) | 1.59363046 |
98 | Atonic seizures (HP:0010819) | 1.58073473 |
99 | Restlessness (HP:0000711) | 1.56673335 |
100 | Severe combined immunodeficiency (HP:0004430) | 1.56622057 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PNCK | 4.83938246 |
2 | PINK1 | 3.80122569 |
3 | MARK1 | 3.78053174 |
4 | MAPKAPK5 | 3.74323337 |
5 | DAPK2 | 2.92654820 |
6 | GRK1 | 2.76560188 |
7 | CSNK1G2 | 2.72792482 |
8 | PAK3 | 2.68039109 |
9 | CSNK1G3 | 2.54121961 |
10 | BUB1 | 2.45268024 |
11 | DYRK2 | 2.21424875 |
12 | LATS1 | 2.10477207 |
13 | CSNK1G1 | 2.09691689 |
14 | WNK4 | 2.08408877 |
15 | BCKDK | 2.03279557 |
16 | TNIK | 1.95079185 |
17 | EPHA4 | 1.94687159 |
18 | BRAF | 1.92917599 |
19 | AKT3 | 1.86977588 |
20 | CAMK1G | 1.85945124 |
21 | MAP3K12 | 1.82889043 |
22 | CASK | 1.76291301 |
23 | NUAK1 | 1.58769694 |
24 | NTRK2 | 1.49539343 |
25 | WNK1 | 1.45775929 |
26 | CAMK2B | 1.41627410 |
27 | ADRBK2 | 1.40229492 |
28 | GRK5 | 1.36922105 |
29 | MINK1 | 1.28125820 |
30 | TAOK1 | 1.24728217 |
31 | MAP3K4 | 1.18931885 |
32 | RPS6KA5 | 1.18379821 |
33 | CAMK2A | 1.18101949 |
34 | CAMK2D | 1.16060479 |
35 | PLK2 | 1.08889343 |
36 | PRKCG | 1.05598026 |
37 | MAPK13 | 1.04951242 |
38 | CSNK1A1L | 1.02530034 |
39 | WNK3 | 1.00989434 |
40 | STK39 | 0.99457259 |
41 | MAP2K4 | 0.95942637 |
42 | OXSR1 | 0.95049084 |
43 | BRD4 | 0.94366602 |
44 | CAMK2G | 0.93407792 |
45 | BMPR1B | 0.92678674 |
46 | PHKG2 | 0.92592338 |
47 | PHKG1 | 0.92592338 |
48 | BCR | 0.91888809 |
49 | SGK494 | 0.91773981 |
50 | SGK223 | 0.91773981 |
51 | PAK6 | 0.88009385 |
52 | FRK | 0.84990186 |
53 | PRKCE | 0.84887486 |
54 | DYRK1A | 0.75349253 |
55 | MAP2K7 | 0.74663332 |
56 | MAP4K2 | 0.74623838 |
57 | MST4 | 0.73161498 |
58 | TAOK3 | 0.68555947 |
59 | SGK2 | 0.68547817 |
60 | PRKACB | 0.67872532 |
61 | PLK4 | 0.65395738 |
62 | CDK5 | 0.63893166 |
63 | ZAK | 0.61102566 |
64 | DYRK3 | 0.60790422 |
65 | PTK6 | 0.60733246 |
66 | ADRBK1 | 0.60634525 |
67 | PDGFRA | 0.56231252 |
68 | MAP3K9 | 0.55845027 |
69 | HIPK2 | 0.55065225 |
70 | CSNK1A1 | 0.54785088 |
71 | CDK14 | 0.49584376 |
72 | CDK18 | 0.46973751 |
73 | CSNK1D | 0.46819944 |
74 | CDK15 | 0.46421457 |
75 | STK38L | 0.45444004 |
76 | PIK3CA | 0.43659164 |
77 | DYRK1B | 0.41922588 |
78 | TIE1 | 0.41210861 |
79 | TESK2 | 0.40207481 |
80 | EPHA3 | 0.40177852 |
81 | PRKG1 | 0.39770870 |
82 | STK3 | 0.39442787 |
83 | INSRR | 0.39412323 |
84 | CSNK1E | 0.37579907 |
85 | CDK11A | 0.37178187 |
86 | FLT3 | 0.36825488 |
87 | PRKACA | 0.36773658 |
88 | SGK1 | 0.36752142 |
89 | LATS2 | 0.31873968 |
90 | NEK6 | 0.30253750 |
91 | NTRK3 | 0.29064209 |
92 | RPS6KA3 | 0.28081016 |
93 | CHUK | 0.27185303 |
94 | PTK2B | 0.26915755 |
95 | PRKCH | 0.26728733 |
96 | SGK3 | 0.25437897 |
97 | KSR1 | 0.25174718 |
98 | PRKACG | 0.25161133 |
99 | PRKCZ | 0.22460134 |
100 | ITK | 0.20159426 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Cocaine addiction_Homo sapiens_hsa05030 | 3.76171872 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.48130887 |
3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.84682311 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.79148245 |
5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.71224796 |
6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.68064749 |
7 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.54758577 |
8 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.54728424 |
9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.50780200 |
10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.40213542 |
11 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.21286740 |
12 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.16426275 |
13 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.11502782 |
14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.01492757 |
15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.99617025 |
16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.93108259 |
17 | Morphine addiction_Homo sapiens_hsa05032 | 1.89611448 |
18 | Phototransduction_Homo sapiens_hsa04744 | 1.84217491 |
19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.79125143 |
20 | GABAergic synapse_Homo sapiens_hsa04727 | 1.77585523 |
21 | Long-term depression_Homo sapiens_hsa04730 | 1.77416958 |
22 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.75639127 |
23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.67291237 |
24 | Circadian entrainment_Homo sapiens_hsa04713 | 1.65930524 |
25 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.61697818 |
26 | Insulin secretion_Homo sapiens_hsa04911 | 1.60089700 |
27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.55273588 |
28 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.52112766 |
29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.47298807 |
30 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.43692048 |
31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.37521675 |
32 | Taste transduction_Homo sapiens_hsa04742 | 1.37448221 |
33 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.37168712 |
34 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.27039572 |
35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21348362 |
36 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.13556569 |
37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11739916 |
38 | Axon guidance_Homo sapiens_hsa04360 | 1.08421711 |
39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.07171290 |
40 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.06108271 |
41 | Olfactory transduction_Homo sapiens_hsa04740 | 1.06053474 |
42 | Alcoholism_Homo sapiens_hsa05034 | 0.99845553 |
43 | Protein export_Homo sapiens_hsa03060 | 0.99382863 |
44 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96702151 |
45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.95945413 |
46 | Peroxisome_Homo sapiens_hsa04146 | 0.89066477 |
47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.88482703 |
48 | Melanoma_Homo sapiens_hsa05218 | 0.87222796 |
49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86402935 |
50 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85058456 |
51 | Huntingtons disease_Homo sapiens_hsa05016 | 0.84622156 |
52 | Alzheimers disease_Homo sapiens_hsa05010 | 0.81672707 |
53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77527880 |
54 | Salivary secretion_Homo sapiens_hsa04970 | 0.76279773 |
55 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73132098 |
56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71877548 |
57 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.68759605 |
58 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.68598045 |
59 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.62049919 |
60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62028757 |
61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60022594 |
62 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59493003 |
63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.54848856 |
64 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.54440626 |
65 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.54019564 |
66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53611524 |
67 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52884878 |
68 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.51881057 |
69 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50445749 |
70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49507113 |
71 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.47495487 |
72 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.46734663 |
73 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.46166073 |
74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45649754 |
75 | Gap junction_Homo sapiens_hsa04540 | 0.45152982 |
76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.44820434 |
77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43504508 |
78 | Asthma_Homo sapiens_hsa05310 | 0.41972560 |
79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40802644 |
80 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40148075 |
81 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.39087596 |
82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38822416 |
83 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38284973 |
84 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.38050456 |
85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.37781172 |
86 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.34731779 |
87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34559385 |
88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33474779 |
89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.33413567 |
90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.30917071 |
91 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.29458930 |
92 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.28295452 |
93 | Tight junction_Homo sapiens_hsa04530 | 0.28150865 |
94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.25840519 |
95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24132145 |
96 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22972984 |
97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22636323 |
98 | Lysine degradation_Homo sapiens_hsa00310 | 0.22443819 |
99 | Basal transcription factors_Homo sapiens_hsa03022 | 0.21101028 |
100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.20479668 |